16-71626261-G-A

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_052858.6(MARVELD3):​c.32G>A​(p.Arg11Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000249 in 1,526,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R11P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

MARVELD3
NM_052858.6 missense

Scores

3
6
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.52

Publications

0 publications found
Variant links:
Genes affected
MARVELD3 (HGNC:30525): (MARVEL domain containing 3) Enables mitogen-activated protein kinase kinase kinase binding activity. Involved in bicellular tight junction assembly. Acts upstream of or within several processes, including negative regulation of JNK cascade; negative regulation of epithelial cell migration; and negative regulation of epithelial cell proliferation. Located in bicellular tight junction and cytoplasmic vesicle. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.28752667).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MARVELD3NM_052858.6 linkc.32G>A p.Arg11Gln missense_variant Exon 1 of 3 ENST00000268485.8 NP_443090.4 Q96A59-1
MARVELD3NM_001017967.4 linkc.32G>A p.Arg11Gln missense_variant Exon 1 of 3 NP_001017967.2 Q96A59-2
MARVELD3NM_001271329.2 linkc.32G>A p.Arg11Gln missense_variant Exon 1 of 3 NP_001258258.1 Q96A59-3
MARVELD3XM_011523449.4 linkc.32G>A p.Arg11Gln missense_variant Exon 1 of 3 XP_011521751.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MARVELD3ENST00000268485.8 linkc.32G>A p.Arg11Gln missense_variant Exon 1 of 3 1 NM_052858.6 ENSP00000268485.3 Q96A59-1

Frequencies

GnomAD3 genomes
AF:
0.0000330
AC:
5
AN:
151740
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000142
AC:
18
AN:
126316
AF XY:
0.000174
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000854
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000240
AC:
33
AN:
1374662
Hom.:
0
Cov.:
61
AF XY:
0.0000296
AC XY:
20
AN XY:
676258
show subpopulations
African (AFR)
AF:
0.0000654
AC:
2
AN:
30558
American (AMR)
AF:
0.000660
AC:
21
AN:
31836
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23968
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35346
South Asian (SAS)
AF:
0.0000131
AC:
1
AN:
76462
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44790
Middle Eastern (MID)
AF:
0.000184
AC:
1
AN:
5434
European-Non Finnish (NFE)
AF:
0.00000468
AC:
5
AN:
1069512
Other (OTH)
AF:
0.0000529
AC:
3
AN:
56756
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.569
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000330
AC:
5
AN:
151740
Hom.:
0
Cov.:
32
AF XY:
0.0000270
AC XY:
2
AN XY:
74116
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41314
American (AMR)
AF:
0.000262
AC:
4
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67852
Other (OTH)
AF:
0.00
AC:
0
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000718
ExAC
AF:
0.0000322
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 25, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.32G>A (p.R11Q) alteration is located in exon 1 (coding exon 1) of the MARVELD3 gene. This alteration results from a G to A substitution at nucleotide position 32, causing the arginine (R) at amino acid position 11 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.30
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.049
T;.;T;.
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.68
T;T;T;T
M_CAP
Pathogenic
0.72
D
MetaRNN
Benign
0.29
T;T;T;T
MetaSVM
Benign
-0.53
T
MutationAssessor
Uncertain
2.0
.;M;M;M
PhyloP100
2.5
PrimateAI
Pathogenic
0.84
D
PROVEAN
Uncertain
-3.0
.;D;N;N
REVEL
Benign
0.17
Sift
Pathogenic
0.0
.;D;D;D
Sift4G
Uncertain
0.015
D;D;D;T
Polyphen
1.0
.;.;D;D
Vest4
0.094
MutPred
0.36
Gain of relative solvent accessibility (P = 0.0166);Gain of relative solvent accessibility (P = 0.0166);Gain of relative solvent accessibility (P = 0.0166);Gain of relative solvent accessibility (P = 0.0166);
MVP
0.37
MPC
0.26
ClinPred
0.41
T
GERP RS
4.1
PromoterAI
0.013
Neutral
Varity_R
0.37
gMVP
0.36
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs763736205; hg19: chr16-71660164; API